Last updated on September 2020

A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease

Brief description of study

TARGET-IBD is a 5-year, longitudinal, observational study of adult and pediatric patients (age 2 and above) being managed for Inflammatory Bowel Disease (IBD) in usual clinical practice. TARGET-IBD will create a research registry of patients with IBD within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.

Clinical Study Identifier: NCT03251118

Find a site near you

Start Over

Digestive Health Specialists, PA

Winston-Salem, NC United States
  Connect »

Stanford University

Stanford, CA United States
  Connect »

Gastro Florida

Clearwater, FL United States
  Connect »

Gastroenterology Associates

Baton Rouge, LA United States
  Connect »

Om Research

Lancaster, CA United States
  Connect »

University of North Carolina

Chapel Hill, NC United States
  Connect »

Saint Louis University

Saint Louis, MO United States
  Connect »

University of Pennsylvania

Philadelphia, PA United States
  Connect »

FACEY Medical Foundation

Mission Hills, CA United States
  Connect »

Atlanta Gastro

Atlanta, GA United States
  Connect »

Louisiana Research Center, LLC

Shreveport, LA United States
  Connect »

NYU Langone Health

New York, NY United States
  Connect »

Baylor College of Medicine

Houston, TX United States
  Connect »

Swedish Medical Center

Seattle, WA United States
  Connect »

UT Southwestern

Dallas, TX United States
  Connect »

University of Minnesota

Minneapolis, MN United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.